Login
$EDIT
$1.96 +$0.09 (4.81%) After hours

Insider Transactions

What Editas Medicine, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 5 16
Total trades 7 18

Shares traded

3 months 12 months
Acquired 60,100 60,100
Disposed 35,264 70,839
Net activity +24,836 −10,739

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Nov 11 Open-market sale · S −7,814 $2.42 −$18.9K 70,379
O'Neill Gilmore Neil CEO Nov 11 Open-market sale · S −21,164 $2.42 −$51.1K 265,592
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Nov 05 Grant / award · A +16,533 — — 78,193
O'Neill Gilmore Neil CEO Nov 05 Grant / award · A +43,567 — — 286,756
Parison Amy SVP, Chief Financial Officer Sep 03 Open-market sale · S −453 $3.04 −$1.38K 13,839
O'Neill Gilmore Neil CEO Sep 03 Open-market sale · S −5,124 $3.04 −$15.6K 243,189
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Sep 03 Open-market sale · S −709 $3.04 −$2.15K 61,660
Parison Amy SVP, Chief Financial Officer Aug 03 Open-market sale · S −678 $2.58 −$1.75K 14,292
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Jul 28 Open-market sale · S −4,928 $2.67 −$13.2K 62,369
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Jun 03 Open-market sale · S −731 $2.70 −$1.97K 67,297
O'Neill Gilmore Neil CEO Jun 03 Open-market sale · S −15,380 $2.70 −$41.5K 248,313
Parison Amy SVP, Chief Financial Officer Jun 03 Open-market sale · S −464 $2.70 −$1.25K 14,970
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Mar 03 Open-market sale · S −749 $2.02 −$1.51K 68,028
O'Neill Gilmore Neil CEO Mar 03 Open-market sale · S −5,394 $2.02 −$10.9K 263,693
Parison Amy SVP, Chief Financial Officer Mar 03 Open-market sale · S −474 $2.02 −$957 15,434
O'Neill Gilmore Neil CEO Dec 03 Open-market sale · S −5,603 $2.15 −$12.1K 269,087
Parison Amy SVP, Chief Financial Officer Dec 03 Open-market sale · S −461 $2.15 −$993 15,908
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Dec 03 Open-market sale · S −713 $2.15 −$1.54K 68,777
Parison Amy SVP, Chief Financial Officer Sep 03 Open-market sale · S −458 $2.60 −$1.19K 16,369
O'Neill Gilmore Neil CEO Sep 03 Open-market sale · S −5,592 $2.60 −$14.5K 274,690

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support